Novartis Partners with Sinopharm for Commercial Promotion of Gleevec and Exjade in China
Swiss giant Novartis (NYSE: NVS) entered into a promotion agreement with China-based Sinopharm Group Co.,...
Luye Pharma Partners with Nhwa and Fine Hin to Commercialize Toludesvenlafaxine
China-based Luye Pharma Group (HKG: 2186), Jiangsu Nhwa Pharmaceutical Co., Ltd (SHE: 002262), and Beijing...
Pediatrix Therapeutics Licenses Tris Pharma’s ADHD Portfolio for Greater China
China-based Pediatrix Therapeutics announced a licensing agreement with US firm Tris Pharma, Inc., obtaining exclusive...
Hainan’s New Regulations on Medical Devices in Boao Lecheng to Take Effect in 2023
The “Regulations on the Administration of Medical Devices in Boao Lecheng International Medical Tourism Pilot...
Kintor’s KX-826 Reaches Primary Endpoint in Phase II Study for Female AGA
China-based Kintor Pharmaceutical Ltd (HKG: 9939) announced that the Phase II clinical study for its...
Sansure Biotech’s Pertussis Detection Kit Approved by NMPA
China-based molecular diagnostics specialist Sansure Biotech Inc. (SHA: 688289) announced that it has obtained medical...
Simcere’s Edaravone, Borneol Sublingual Tablets Reach Phase III Efficacy Endpoint
Jiangsu Simcere Pharmaceutical Co., Ltd (HKG: 2096) announced that a Phase III clinical study for...
AI Model for Early Alzheimer’s Detection Using Retinal Photographs Published
A joint Singapore-UK-Hong Kong research team has published details of an AI-based deep learning model...
XJTLU and University of Liverpool Launch Joint Centre for Pharmacology and Therapeutics
The Suzhou-based Xi’an Jiaotong-Liverpool University (XJTLU) and the UK’s University of Liverpool earlier this month...
Yifan Pharmaceutical Licenses F-627 to Acrotech for US Distribution
China-based Yifan Pharmaceutical Co., Ltd (SHE: 002019) announced the establishment of a licensing agreement with...
Nans Tech Secures Series A Funding for Brain Dysfunction Digital Therapies
Nans Tech, a brain dysfunction digital therapy developer based in Hangzhou, reportedly raised “tens of...
Aclaris Therapeutics Licenses JAK Inhibitor ATI-1777 to Pediatrix for Greater China
US-based Aclaris Therapeutics Inc. (NASDAQ: ACRS) and Shanghai firm Pediatrix Therapeutics Inc. entered into a...
China’s NMPA Issues New GSP Appendix for Drug Retailing Quality Management
China’s National Medical Products Administration (NMPA) has released “Good Supply Practice (GSP) Appendix 6: Quality...
ImmuneOnco Initiates Phase II Clinical Study for CD47 Antibody IMM01
ImmuneOnco Biopharmaceuticals (Shanghai) Co., Ltd has announced the initiation of a Phase II clinical study...
China’s NMPA Seeks Feedback on Drug Quality Management Provisions
China’s National Medical Products Administration (NMPA) has released a draft proposal titled “Provisions on the...
Luye Pharma’s Shandong Boan Bio Files for Hong Kong IPO
China-based Luye Pharma Group’s (HKG: 2186) controlling subsidiary, Shandong Boan Biotechnology Co., Ltd, has filed...
Luca Healthcare Partners with Cambridge Cognition to Launch Cognitive Tools in China
China-based digital health solutions provider Luca Healthcare has announced a strategic partnership and license agreement...
Luye Pharma’s Biosimilar to Amgen’s Xgeva Launched in China
China-based Luye Pharma Group (HKG: 2186) has announced the first prescription of its biosimilar version...
Assure Tech Wins Japanese PDMA Approval for Pen-Type COVID-19 Antigen Test
China-based Assure Tech (Hangzhou) Co., Ltd (SHA: 688075) has announced receiving marketing approval from Japan’s...
Double-Crane Pharma Gains NMPA Approval for COVID-19 Drug CX2101A Clinical Trials
China Resources Double-Crane Pharmaceutical Co., Ltd (SHA: 600062) has announced receiving clinical trial approval from...